In the bone marrow microenvironment, the binding of MM cells to BMSCs triggers the secretion of cytokines such as VEGF and IL-6 to promote MM cell growth, survival, migration, and chemotherapeutic resistance (1, 44). The gene discussed is IL6; the disease is Miyoshi myopathy.